Alnylam Pharmaceuticals, Inc. ALNY
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.59B | 3.31B | 3.01B | 2.91B | 2.72B |
| Total Receivables | 1.08B | 912.74M | 883.96M | 777.57M | 964.77M |
| Inventory | 105.91M | 97.11M | 84.03M | 82.72M | 75.38M |
| Prepaid Expenses | 334.60M | 302.18M | 242.10M | 281.89M | 188.04M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 5.11B | 4.62B | 4.22B | 4.05B | 3.95B |
|
|
|||||
| Total Current Assets | 5.11B | 4.62B | 4.22B | 4.05B | 3.95B |
| Net Property, Plant & Equipment | 792.86M | 737.50M | 707.56M | 708.06M | 693.14M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.09B | 201.10M | 202.68M | 207.61M | 205.71M |
| Total Assets | 7.99B | 5.56B | 5.13B | 4.97B | 4.85B |
|
|
|||||
| Total Accounts Payable | 135.40M | 108.02M | 126.63M | 115.72M | 117.59M |
| Total Accrued Expenses | 1.24B | 1.10B | 946.49M | 821.34M | 1.15B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 679.65M | 304.50M | 273.15M | 265.59M | 160.45M |
| Total Finance Division Other Current Liabilities | 11.67M | 4.01M | 3.21M | 263.70M | 123.79M |
| Total Other Current Liabilities | 11.67M | 4.01M | 3.21M | 263.70M | 123.79M |
| Total Current Liabilities | 2.06B | 1.51B | 1.35B | 1.47B | 1.56B |
|
|
|||||
| Total Current Liabilities | 2.06B | 1.51B | 1.35B | 1.47B | 1.56B |
| Long-Term Debt | 2.11B | 2.47B | 2.48B | 2.48B | 2.39B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 203.29M | 210.50M | 218.03M | 225.09M | 223.42M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.61M | 9.15M | 7.61M | 7.59M | 449.43M |
| Total Liabilities | 4.39B | 4.20B | 4.05B | 4.18B | 4.62B |
|
|
|||||
| Common Stock & APIC | 7.81B | 7.72B | 7.60B | 7.51B | 7.42B |
| Retained Earnings | -4.16B | -6.33B | -6.50B | -6.70B | -7.16B |
| Treasury Stock & Other | -44.66M | -32.14M | -24.89M | -20.10M | -21.78M |
| Total Common Equity | 3.60B | 1.35B | 1.08B | 789.18M | 233.89M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.60B | 1.35B | 1.08B | 789.18M | 233.89M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.60B | 1.35B | 1.08B | 789.18M | 233.89M |
|
|
|||||